PAVmed Inc (PAVM) has released an update.
On January 26, 2024, PAVmed Inc. chose to receive over $4.67 million owed by its subsidiary, Lucid Diagnostics, in the form of 3,331,771 shares of Lucid Diagnostics’ common stock. Further details of these transactions were provided in a Current Report filed by Lucid Diagnostics four days later.
For further insights into PAVM stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
